Evidence map›Paper›PMID 37842820›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making

Development and Validation of the US Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model: Health Disparity and Economic Impact Model.

David D Kim, Lu Wang, Brianna N Lauren, Junxiu Liu, Matti Marklund, Yujin Lee, Renata Micha, Dariush Mozaffarian, John B Wong

Open access · hybridAbstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

David D KimSection of Hospital Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID 0000-0002-3383-8972
Lu WangFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
Brianna N LaurenFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
Junxiu LiuDepartment of Population Health Science and Policy, the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Matti MarklundThe George Institute for Global Health, University of New South Wales, Sydney, Australia.ORCID 0000-0002-3320-796X
Yujin LeeDepartment of Food and Nutrition, Myongji University, Yongin, South Korea.
Renata MichaFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
Dariush MozaffarianFriedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
John B WongDivision of Clinical Decision Making, Tufts Medical Center, Boston, MA, USA.
Tufts University · USIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USMyongji University · KRTufts Medical Center · USUniversity of Chicago · US

Funding

Cost-Effectiveness of Health System and State-Level Strategies to Improve Diet and Reduce Cardiometabolic DiseasesR01HL115189 · NHLBI · TUFTS UNIVERSITY BOSTON · PI DARIUSH MOZAFFARIAN · 2013 to 2026
$8.2M
Economic Analyses of Policy Strategies to Improve Diet and Reduce CVDR01HL130735 · NHLBI · TUFTS UNIVERSITY BOSTON · PI MICHA, EIRINI (RENATA) · 2016 to 2019
$3.1M
NHLBI NIH HHS R01 HL115189NHLBI NIH HHS R01 HL130735
6 · The paper itself

Abstract

backgroundFew simulation models have incorporated the interplay of diabetes, obesity, and cardiovascular disease (CVD); their upstream lifestyle and biological risk factors; and their downstream effects on health disparities and economic consequences.

methodsWe developed and validated a US Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) model that incorporates demographic, clinical, and lifestyle risk factors to jointly predict overall and racial-ethnic groups-specific obesity, diabetes, CVD, and cause-specific mortality for the US adult population aged 40 to 79 y at baseline. An individualized health care cost prediction model was further developed and integrated. This model incorporates nationally representative data on baseline demographics, lifestyle, health, and cause-specific mortality; dynamic changes in modifiable risk factors over time; and parameter uncertainty using probabilistic distributions. Validation analyses included assessment of 1) population-level risk calibration and 2) individual-level risk discrimination. To illustrate the application of the DOC-M model, we evaluated the long-term cost-effectiveness of a national produce prescription program.

resultsComparing the 15-y model-predicted population risk of primary outcomes among the 2001-2002 National Health and Nutrition Examination Survey (NHANES) cohort with the observed prevalence from age-matched cross-sectional 2003-2016 NHANES cohorts, calibration performance was strong based on observed-to-expected ratio and calibration plot analysis. In most cases, Brier scores fell below 0.0004, indicating a low overall prediction error. Using the Multi-Ethnic Study of Atherosclerosis cohorts, the c-statistics for assessing individual-level risk discrimination were 0.85 to 0.88 for diabetes, 0.93 to 0.95 for obesity, 0.74 to 0.76 for CVD history, and 0.78 to 0.81 for all-cause mortality, both overall and in three racial-ethnic groups. Open-source code for the model was posted at https://github.com/food-price/DOC-M-Model-Development-and-Validation.

conclusionsThe validated DOC-M model can be used to examine health, equity, and the economic impact of health policies and interventions on behavioral and clinical risk factors for obesity, diabetes, and CVD. HIGHLIGHTS: We developed a novel microsimula'tion model for obesity, diabetes, and CVD, which intersect together and - critically for prevention and treatment interventions - share common lifestyle, biologic, and demographic risk factors.Validation analyses, including assessment of (1) population-level risk calibration and (2) individual-level risk discrimination, showed strong performance across the overall population and three major racial-ethnic groups for 6 outcomes (obesity, diabetes, CVD, and all-cause mortality, CVD- and DM-cause mortality)This paper provides a thorough explanation and documentation of the development and validation process of a novel microsimulation model, along with the open-source code (https://github.com/food-price/ DOCM_validation) for public use, to serve as a guide for future simulation model assessments, validation, and implementation.

Indexed as

Cardiovascular DiseasesDiabetes MellitusAdultCross-Sectional StudiesHumansNutrition SurveysObesityRisk Factorscalibrationcardiovascular diseasediabetesmicrosimulation modelobesityvalidation

Identifiers

PMID37842820
PMCPMC10625721
OpenAlexW4387661181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.